LETRAZOLE Tablets IP 2.5 MG – OPTILET 2.5 Tablets

Optilet-2.5
Composition: LETROZOLE H

OPTILET 2.5 Tablets –  LETRAZOLE Tablets IP 2.5 MG is used for the treatment of hormone-dependent breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which helps slow down or stop the growth of cancer cells that depend on this hormone. Doctors may also prescribe it for fertility treatment in some women to help stimulate ovulation. It should be taken only under medical supervision, as dosage varies based on the patient’s condition.

LETROZOLE H — Optilet-2.5: Hormone-Targeted Care for Postmenopausal Breast Cancer

• Active Ingredient: Contains Letrozole 2.5 mg, an aromatase inhibitor used for hormone-dependent breast cancer in postmenopausal women.
• Dual Mechanism: Blocks estrogen production and slows tumour growth driven by hormonal stimulation.
• Better Tolerability: Generally well-tolerated with manageable side effects under medical supervision.
• Mode of Action: Reduces estrogen levels in the body, helping suppress cancer cell growth and progression effectively.

Can be prescribed by: 

• Oncologists
• Surgical oncologists
• Gynecologists
• General physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.